Market Cap (In USD)
1313.00
Revenue (In USD)
-
Net Income (In USD)
-
Avg. Volume
6.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-6-2.0E-4
- PE
- -
- EPS
- -
- Beta Value
- -11.467
- ISIN
- US37959N1028
- CUSIP
- 37959N102
- CIK
- 1598308
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Mr. Edgar B. Gonzalez
- Employee Count
- -
- Website
- https://gwhpcorp.com
- Ipo Date
- 2015-04-09
- Details
- Global WholeHealth Partners Corporation develops and markets various in-vitro diagnostic test kits in the United States. The company offers rapid diagnostic tests, such as the CoVid-19 test, whole blood Ebola test, whole blood Zika test, whole blood rapid TB test, and various other tests for over-the-counter or consumer-use, as well as for point-of-care, which includes hospitals, physicians' offices, and medical clinics. It provides tests for various diseases, such as Ebola, zika, dengue, malaria, influenza, tuberculosis, coronaviruses, and other vector-borne diseases. Global WholeHealth Partners Corporation was incorporated in 2013 and is based in San Clemente, California.
More Stocks
-
NITCONITCO Limited
NITCO
-
1799
-
IHG
-
0II4Equinix, Inc.
0II4
-
RHIMRHI Magnesita N.V.
RHIM
-
KAYPOWRKay Power And Paper Limited
KAYPOWR
-
7727OVAL Corporation
7727
-
CGAS